Skip to main content
Top
Published in: Diabetologia 9/2014

01-09-2014 | Article

A stress response pathway in mice upregulates somatostatin level and transcription in pancreatic delta cells through Gs and β-arrestin 1

Authors: Hong-Mei Wang, Jun-Hong Dong, Qing Li, Qiaoxia Hu, Shang-Lei Ning, Wenshuai Zheng, Min Cui, Tian-Sheng Chen, Xin Xie, Jin-Peng Sun, Xiao Yu

Published in: Diabetologia | Issue 9/2014

Login to get access

Abstract

Aims/hypothesis

Somatostatin secretion from islet delta cells plays an important role in regulating islet function and is tightly controlled by environmental changes. Activation of the adrenergic system promoted somatostatin secretion from islet delta cells; however, the role of the adrenergic system in regulating somatostatin content and transcription has not been defined. An imbalance between the somatostatin content and its secretion may cause dysfunctions in the islet delta cells. We have investigated the role of the adrenergic system in the modulation of somatostatin content and transcription in pancreatic delta cells and the detailed underlying mechanisms of this regulation.

Methods

The stress hormone adrenaline (epinephrine), specific adrenergic agonists or specific adrenergic antagonists were applied to islets from either wild-type or specific adrenergic receptor knockout mice and pancreatic delta cell lines to investigate their effects on somatostatin content and transcription. The GloSensor assay, quantitative real-time PCR, western blots and the dual luciferase assay were used to monitor the cAMP level, somatostatin expression, activations of kinases and transcriptional factors. Arrb1 knockout mice, specific Creb or Pax6 mutations and specific kinase inhibitors were used to dissect the signalling pathway.

Results

Adrenaline and isoprenaline increased somatostatin content and transcription through the activation of β1-/β2-adrenergic receptors (β1-/β2ARs). The somatostatin content in β1AR −/− /β2AR −/− (Adrb1/Adrb2 knockout) mice was 50% lower than in β1AR +/+ /β2AR +/+ mice. Two parallel signalling pathways, Gs–cAMP–protein kinase A (PKA)–cAMP response element binding protein (CREB) and β-arrestin 1–extracellular signal-related kinase (ERK)–paired box protein 6 (PAX6), cooperatively regulated isoprenaline-induced somatostatin transcription.

Conclusions/interpretation

A stress pathway increased somatostatin content and transcription through β-adrenergic agonism. β-Arrestin1, ERK and PAX6 are important pancreatic delta cell regulators in addition to cAMP, PKA and CREB. Dysfunction of β-adrenergic agonism may impair pancreatic delta cell function.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hauge-Evans AC, King AJ, Carmignac D et al (2009) Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes 58:403–411PubMedCentralPubMedCrossRef Hauge-Evans AC, King AJ, Carmignac D et al (2009) Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function. Diabetes 58:403–411PubMedCentralPubMedCrossRef
2.
go back to reference Hauge-Evans AC, Anderson RL, Persaud SJ, Jones PM (2012) Delta cell secretory responses to insulin secretagogues are not mediated indirectly by insulin. Diabetologia 55:1995–2004PubMedCrossRef Hauge-Evans AC, Anderson RL, Persaud SJ, Jones PM (2012) Delta cell secretory responses to insulin secretagogues are not mediated indirectly by insulin. Diabetologia 55:1995–2004PubMedCrossRef
3.
go back to reference Braun M, Ramracheya R, Amisten S et al (2009) Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells. Diabetologia 52:1566–1578PubMedCrossRef Braun M, Ramracheya R, Amisten S et al (2009) Somatostatin release, electrical activity, membrane currents and exocytosis in human pancreatic delta cells. Diabetologia 52:1566–1578PubMedCrossRef
4.
go back to reference Brunicardi FC, Kleinman R, Moldovan S et al (2001) Immunoneutralization of somatostatin, insulin, and glucagon causes alterations in islet cell secretion in the isolated perfused human pancreas. Pancreas 23:302–308PubMedCrossRef Brunicardi FC, Kleinman R, Moldovan S et al (2001) Immunoneutralization of somatostatin, insulin, and glucagon causes alterations in islet cell secretion in the isolated perfused human pancreas. Pancreas 23:302–308PubMedCrossRef
5.
go back to reference Hara MR, Kovacs JJ, Whalen EJ et al (2011) A stress response pathway regulates DNA damage through beta2-adrenoreceptors and beta-arrestin-1. Nature 477:349–353PubMedCentralPubMedCrossRef Hara MR, Kovacs JJ, Whalen EJ et al (2011) A stress response pathway regulates DNA damage through beta2-adrenoreceptors and beta-arrestin-1. Nature 477:349–353PubMedCentralPubMedCrossRef
6.
go back to reference Samols E, Weir GC (1979) Adrenergic modulation of pancreatic A, B, and D cells alpha-adrenergic suppression and beta-adrenergic stimulation of somatostatin secretion, alpha-adrenergic stimulation of glucagon secretion in the perfused dog pancreas. J Clin Invest 63:230–238 Samols E, Weir GC (1979) Adrenergic modulation of pancreatic A, B, and D cells alpha-adrenergic suppression and beta-adrenergic stimulation of somatostatin secretion, alpha-adrenergic stimulation of glucagon secretion in the perfused dog pancreas. J Clin Invest 63:230–238
7.
go back to reference Rizza RA, Cryer PE, Haymond MW, Gerich JE (1980) Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest 65:682–689PubMedCentralPubMedCrossRef Rizza RA, Cryer PE, Haymond MW, Gerich JE (1980) Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest 65:682–689PubMedCentralPubMedCrossRef
8.
go back to reference Boden G, Master RW, Sattler MA, Martin JS, Tansy MF, Owen OE (1982) Adrenergic control of somatostatin release. Endocrinology 111:1166–1172PubMedCrossRef Boden G, Master RW, Sattler MA, Martin JS, Tansy MF, Owen OE (1982) Adrenergic control of somatostatin release. Endocrinology 111:1166–1172PubMedCrossRef
9.
go back to reference Samols E, Stagner JI, Weir GC (1981) Autonomic function and control of pancreatic somatostatin. Diabetologia 20(Suppl):388–392PubMedCrossRef Samols E, Stagner JI, Weir GC (1981) Autonomic function and control of pancreatic somatostatin. Diabetologia 20(Suppl):388–392PubMedCrossRef
10.
go back to reference Bernstein D, Fajardo G, Zhao M et al (2005) Differential cardioprotective/cardiotoxic effects mediated by beta-adrenergic receptor subtypes. Am J Physiol Heart Circ Physiol 289:H2441–H2449PubMedCrossRef Bernstein D, Fajardo G, Zhao M et al (2005) Differential cardioprotective/cardiotoxic effects mediated by beta-adrenergic receptor subtypes. Am J Physiol Heart Circ Physiol 289:H2441–H2449PubMedCrossRef
11.
go back to reference Dou HQ, Xu YF, Sun JP et al (2012) Thiopental-induced insulin secretion via activation of IP3-sensitive calcium stores in rat pancreatic beta-cells. Am J Physiol Cell Physiol 302:C796–C803PubMedCrossRef Dou HQ, Xu YF, Sun JP et al (2012) Thiopental-induced insulin secretion via activation of IP3-sensitive calcium stores in rat pancreatic beta-cells. Am J Physiol Cell Physiol 302:C796–C803PubMedCrossRef
12.
go back to reference Olofsson CS, Salehi A, Holm C, Rorsman P (2004) Palmitate increases L-type Ca2+ currents and the size of the readily releasable granule pool in mouse pancreatic beta-cells. J Physiol 557:935–948PubMedCentralPubMedCrossRef Olofsson CS, Salehi A, Holm C, Rorsman P (2004) Palmitate increases L-type Ca2+ currents and the size of the readily releasable granule pool in mouse pancreatic beta-cells. J Physiol 557:935–948PubMedCentralPubMedCrossRef
14.
16.
go back to reference Dong JH, Chen X, Cui M, Yu X, Pang Q, Sun JP (2012) beta2-adrenergic receptor and astrocyte glucose metabolism. J Mol Neurosci 48:456–463PubMedCrossRef Dong JH, Chen X, Cui M, Yu X, Pang Q, Sun JP (2012) beta2-adrenergic receptor and astrocyte glucose metabolism. J Mol Neurosci 48:456–463PubMedCrossRef
17.
go back to reference Nobles KN, Xiao K, Ahn S et al (2011) Distinct phosphorylation sites on the beta(2)-adrenergic receptor establish a barcode that encodes differential functions of beta-arrestin. Sci Signal 4:ra51PubMedCentralPubMedCrossRef Nobles KN, Xiao K, Ahn S et al (2011) Distinct phosphorylation sites on the beta(2)-adrenergic receptor establish a barcode that encodes differential functions of beta-arrestin. Sci Signal 4:ra51PubMedCentralPubMedCrossRef
18.
go back to reference Morisco C, Condorelli G, Trimarco V et al (2005) Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ Res 96:180–188PubMedCrossRef Morisco C, Condorelli G, Trimarco V et al (2005) Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ Res 96:180–188PubMedCrossRef
19.
go back to reference Quoyer J, Longuet C, Broca C et al (2010) GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells. J Biol Chem 285:1989–2002PubMedCentralPubMedCrossRef Quoyer J, Longuet C, Broca C et al (2010) GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells. J Biol Chem 285:1989–2002PubMedCentralPubMedCrossRef
20.
go back to reference Vallejo M, Penchuk L, Habener JF (1992) Somatostatin gene upstream enhancer element activated by a protein complex consisting of CREB, Isl-1-like, and alpha-CBF-like transcription factors. J Biol Chem 267:12876–12884PubMed Vallejo M, Penchuk L, Habener JF (1992) Somatostatin gene upstream enhancer element activated by a protein complex consisting of CREB, Isl-1-like, and alpha-CBF-like transcription factors. J Biol Chem 267:12876–12884PubMed
21.
go back to reference Montminy M, Brindle P, Arias J, Ferreri K, Armstrong R (1996) Regulation of somatostatin gene transcription by cAMP. Adv Pharmacol 36:1–13PubMedCrossRef Montminy M, Brindle P, Arias J, Ferreri K, Armstrong R (1996) Regulation of somatostatin gene transcription by cAMP. Adv Pharmacol 36:1–13PubMedCrossRef
22.
go back to reference Andersen FG, Jensen J, Heller RS et al (1999) Pax6 and Pdx1 form a functional complex on the rat somatostatin gene upstream enhancer. FEBS Lett 445:315–320PubMedCrossRef Andersen FG, Jensen J, Heller RS et al (1999) Pax6 and Pdx1 form a functional complex on the rat somatostatin gene upstream enhancer. FEBS Lett 445:315–320PubMedCrossRef
23.
go back to reference Montminy MR, Bilezikjian LM (1987) Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 328:175–178PubMedCrossRef Montminy MR, Bilezikjian LM (1987) Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene. Nature 328:175–178PubMedCrossRef
24.
go back to reference Bollheimer LC, Skelly RH, Chester MW, McGarry JD, Rhodes CJ (1998) Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 101:1094–1101PubMedCentralPubMedCrossRef Bollheimer LC, Skelly RH, Chester MW, McGarry JD, Rhodes CJ (1998) Chronic exposure to free fatty acid reduces pancreatic beta cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J Clin Invest 101:1094–1101PubMedCentralPubMedCrossRef
25.
go back to reference Yamamoto KK, Gonzalez GA, Biggs WH 3rd, Montminy MR (1988) Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334:494–498PubMedCrossRef Yamamoto KK, Gonzalez GA, Biggs WH 3rd, Montminy MR (1988) Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334:494–498PubMedCrossRef
26.
go back to reference Hagiwara M, Alberts A, Brindle P et al (1992) Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB. Cell 70:105–113PubMedCrossRef Hagiwara M, Alberts A, Brindle P et al (1992) Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB. Cell 70:105–113PubMedCrossRef
27.
go back to reference Okamoto N, Nishimori Y, Nishimura T (2012) Conserved role for the Dachshund protein with Drosophila Pax6 homolog Eyeless in insulin expression. Proc Natl Acad Sci U S A 109:2406–2411PubMedCentralPubMedCrossRef Okamoto N, Nishimori Y, Nishimura T (2012) Conserved role for the Dachshund protein with Drosophila Pax6 homolog Eyeless in insulin expression. Proc Natl Acad Sci U S A 109:2406–2411PubMedCentralPubMedCrossRef
28.
go back to reference Ahlqvist E, Turrini F, Lang ST et al (2012) A common variant upstream of the PAX6 gene influences islet function in man. Diabetologia 55:94–104PubMedCrossRef Ahlqvist E, Turrini F, Lang ST et al (2012) A common variant upstream of the PAX6 gene influences islet function in man. Diabetologia 55:94–104PubMedCrossRef
29.
go back to reference Hart AW, Mella S, Mendrychowski J, van Heyningen V, Kleinjan DA (2013) The developmental regulator Pax6 is essential for maintenance of islet cell function in the adult mouse pancreas. PLoS One 8:e54173PubMedCentralPubMedCrossRef Hart AW, Mella S, Mendrychowski J, van Heyningen V, Kleinjan DA (2013) The developmental regulator Pax6 is essential for maintenance of islet cell function in the adult mouse pancreas. PLoS One 8:e54173PubMedCentralPubMedCrossRef
30.
go back to reference Sander M, Neubuser A, Kalamaras J, Ee HC, Martin GR, German MS (1997) Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev 11:1662–1673PubMedCrossRef Sander M, Neubuser A, Kalamaras J, Ee HC, Martin GR, German MS (1997) Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev 11:1662–1673PubMedCrossRef
31.
go back to reference Mikkola I, Bruun JA, Bjorkoy G, Holm T, Johansen T (1999) Phosphorylation of the transactivation domain of Pax6 by extracellular signal-regulated kinase and p38 mitogen-activated protein kinase. J Biol Chem 274:15115–15126PubMedCrossRef Mikkola I, Bruun JA, Bjorkoy G, Holm T, Johansen T (1999) Phosphorylation of the transactivation domain of Pax6 by extracellular signal-regulated kinase and p38 mitogen-activated protein kinase. J Biol Chem 274:15115–15126PubMedCrossRef
32.
go back to reference Reiter E, Ahn S, Shukla AK, Lefkowitz RJ (2012) Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol 52:179–197PubMedCentralPubMedCrossRef Reiter E, Ahn S, Shukla AK, Lefkowitz RJ (2012) Molecular mechanism of beta-arrestin-biased agonism at seven-transmembrane receptors. Annu Rev Pharmacol Toxicol 52:179–197PubMedCentralPubMedCrossRef
34.
go back to reference Xiao K, Sun J, Kim J et al (2010) Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR). Proc Natl Acad Sci U S A 107:15299–15304PubMedCentralPubMedCrossRef Xiao K, Sun J, Kim J et al (2010) Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR). Proc Natl Acad Sci U S A 107:15299–15304PubMedCentralPubMedCrossRef
35.
go back to reference Buelli S, Rosano L, Gagliardini E et al (2013) beta-Arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury. J Am Soc Nephrol 25:523–533PubMedCrossRef Buelli S, Rosano L, Gagliardini E et al (2013) beta-Arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury. J Am Soc Nephrol 25:523–533PubMedCrossRef
36.
go back to reference Kong KC, Butcher AJ, McWilliams P et al (2010) M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1. Proc Natl Acad Sci U S A 107:21181–21186PubMedCentralPubMedCrossRef Kong KC, Butcher AJ, McWilliams P et al (2010) M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1. Proc Natl Acad Sci U S A 107:21181–21186PubMedCentralPubMedCrossRef
Metadata
Title
A stress response pathway in mice upregulates somatostatin level and transcription in pancreatic delta cells through Gs and β-arrestin 1
Authors
Hong-Mei Wang
Jun-Hong Dong
Qing Li
Qiaoxia Hu
Shang-Lei Ning
Wenshuai Zheng
Min Cui
Tian-Sheng Chen
Xin Xie
Jin-Peng Sun
Xiao Yu
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 9/2014
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3290-0

Other articles of this Issue 9/2014

Diabetologia 9/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.